In the webcast, the panelists will discuss the goals of the REMS and steps clinicians can take to prevent prenatal exposure to a potent teratogenic medication.
To register, visit: https://www.cmeoutfitters.com/activity/implementing-the-mycophenolate-risk-evaluation-and-mitigation-strategy-in-clinical-practice/
